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Abstract
Background: Previous studies have demonstrated that QX-314, an intracellular sodium channel blocker, can enter into
nociceptors through capsaicin-activated TRPV1 or permeation of the membrane by chemical enhancers to produce a
sensory-selective blockade. However, the obvious side effects of these combinations limit the application of QX-314. A new
strategy for targeting delivery of QX-314 into nociceptors needs further investigation. The aim of this study is to test
whether acidic QX-314, when dissolves in acidic solution directly, can enter into nociceptors through acid-activated TRPV1
and block sodium channels from the intracellular side to produce a sensory-specific analgesic effect.
Methodology/Principal Findings: Acidic solution or noradrenaline was injected intraplantarly to induce acute pain behavior
in mice. A chronic constrictive injury model was performed to induce chronic neuropathic pain. A sciatic nerve blockade
model was used to evaluate the sensory-specific analgesic effects of acidic QX-314. Thermal and mechanical hyperalgesia
were measured by using radiant heat and electronic von Frey filaments test. Spinal Fos protein expression was determined
by immunohistochemistry. The expression of p-ERK was detected by western blot assay. Whole cell clamp recording was
performed to measure action potentials and total sodium current in rats DRG neurons. We found that pH 5.0 PBS solution
induced behavioral hyperalgesia accompanied with the increased expression of spinal Fos protein and p-ERK. Pretreatment
with pH 5.0 QX-314, and not pH 7.4 QX-314, alleviated pain behavior, inhibited the increased spinal Fos protein and p-ERK
expression induced by pH 5.0 PBS or norepinephrine, blocked sodium currents and abolished the production of action
potentials evoked by current injection. The above effects were prevented by TRPV1 channel inhibitor SB366791, but not by
ASIC channel inhibitor amiloride. Furthermore, acidic QX-314 employed adjacent to the sciatic nerve selectively blocked the
sensory but not the motor functions in naı ¨ve and CCI mice.
Conclusions/Significance: Acid solution is a suitable medium for introducing QX-314 into nociceptors through TRPV1
channels to produce a sensory-specific analgesic effect.
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Introduction
Peripheralnervesservemainlythreefunctions,includingsensation,
movement and autonomic modulation. Most local anesthetics (LA)
currently employed in clinics produce a blockade of sensory, motor
and autonomic nerves via blocking voltage-gated Na
+ channels to
induce analgesia, muscle relaxation (immobility) and loss of peri-
pheral autonomic modulation [1,2]. However, in some clinical cases,
LA that selectively block of sensory nerves are more ideal.
QX-314, a membrane-impermeable quaternary lidocaine
derivative, has no effect on neuronal sodium channels with
extracellular application but does block sodium channels when
applied intracellularly. Woolf and colleagues reported that a long-
lasting sensory-selective blockage was produced by co-administra-
tion of QX-314 and capsaicin, a transient receptor potential cation
channel, subfamily V, member 1 (TRPV1) agonist [3,4,5,6,7].
TRPV1 channels are only expressed on the nociceptors. Activat-
ing TRPV1 channels by capsaicin allowed QX-314 to enter into
TRPV1 positive neurons only, where it then blocks the sodium
channels from the intracellular side and then produces an analge-
sic effect without interfering with motor function [3,4,5,6,7].
Recent findings have indicated that co-application of chemical
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lammonium bromide and QX-314 also produced a similar effect
[7]. However, application of capsaicin or chemical permeability
enhancers would produce some adverse effects including acute
pain and potential neurotoxicity et al [8,9,10]. These combina-
tions are also inconvenient for clinical use. Therefore, investigation
of a new strategy for targeting delivery of QX-314 into nociceptors
is needed.
The TRPV1 channels are non-selective cation channels that
serve as a pain-sensing transducer and express peripherally in
primary afferent nociceptors, which can be activated by capsaicin,
noxious heat (.43uC), protons (pH,5.9) and various inflamma-
tory mediators [11,12,13,14]. Most LA applied widely in clinical
settings now is dissolved in an acidic solution (pH 3.3,5.5). So, we
want to know whether acidic QX-314 (directly dissolved in pH 5.0
PBS) could be used to selectively target nociceptors and produce
sensory-selective blockage via proton activated-TRPV1 channels,
as capsaicin did.
Materials and Methods
Animals
Adult male Kunming mice (18–22 -g) and Sprague-Dawley rats
(6–8 weeks) employed in present studies were provided by
Experimental Animal Center of Xuzhou Medical College. Mice
were housed with controlled relative humidity (20–30%) and
temperature (2362- uC), under a 12 h light-dark cycle (light on
08:00 to 20:00), and with free access to food and water ad libitum.
Before experiments, the animals were allowed to habituate to the
housing facilities for 7 days and efforts were made to limit distress
to the animals. All experimental protocols were approved by the
Animal Care and Use Committee of Xuzhou Medical College
(Xuzhou, Jiangsu Province, China) and according to the
Declaration of National Institutes of Health Guide for Care and Use
of Laboratory Animals (Publication No. 80–23, revised 1996).
Drug application
N-(2, 6-dimethylphenyl carbamoylmethyl) triethylammonium
chloride (QX-314) and 5-(N-Methyl-N-isobutyl) amiloride, a non–
selective acid-sensing ion channel (ASIC) antagonist, were
purchased from Sigma-Aldrich (St. Louis, MO). N-(3-Methox-
yphenyl)-4-chlorocinnamide (SB366791), a potent and selective
TRPV1 antagonist, was purchased from Enzo Life Sciences (San
Diego, CA). SB366791 was dissolved in dimethyl sulfoxide
(DMSO) for stock solution (25-mg/ml) and other drugs in PBS.
The final DMSO concentration was less than 1% for behavior test
and 0.1% for electrophysiological experiments. PBS was titrated
with NaOH or HCl as needed. All doses of drugs were based on
the results of preliminary experiments. The doses of each drug and
time points of treatment are presented in parts of the results and
figure legends.
Mice were gently restrained, and all drugs or vehicles were
administered in a volume of 10-ml into the plantar surface of the
right hind paw using a 25-ml Hamilton syringe with a 28-gauge
needle. The needle was inserted into the plantar skin proximal to
the midpoint of the hind paw and advanced about 10-mm so that
it reached the midpoint of the hind paw, then the solution was
injected to form a bleb which disappeared within 10-min.
Measurement of thermal hyperalgesia
Thermal hyperalgesia was measured by the IITC Plantar
Analgesia Meter (IITC Life Science Inc., Victory Blvd Woodland
Hills, CA) for paw withdrawal latency according to the method
described by Hargreaves et al [15]. In brief, mice were placed in
transparent acrylic enclosures (769611-cm) with a glass plate, and
allowed to acclimatize to their environment for 1-h before testing
in a temperature-controlled and noise-free room (2362-uC). The
high-intensity, movable radiant heat source was placed under-
neath the glass and focused onto the plantar surface of each hind
paw. The nociceptive endpoint in the radiant heat test was
characteristic lifting or licking of the hind paw. The time from
onset of radiant heat to endpoint was considered as the paw
withdrawal latency (PWL). The radiant heat intensity was adjusted
at the beginning of the experiment to obtain basal PWL of 12,15-
s, and kept constant thereafter. An automatic 25-s cutoff was used
to prevent tissue damage. Each animal was tested 3 times on each
hind paw at intervals of 5-min.
Measurement of mechanical allodynia
Mechanical allodynia was assessed by using electronic von Frey
filaments (IITC Life Science Inc., Victory Blvd Woodland Hills,
CA). Animals were placed in individual plastic boxes (20625615-
cm) on a metal mesh floor and allowed to acclimate for 1-h. The
filaments were presented, in ascending order of strength, per-
pendicular to the plantar surface with sufficient force to cause
slight bending against the paw and held for 6–8-s. Brisk with-
drawal or paw flinching was considered as positive responses. The
paw withdrawal threshold (PWT) was determined by sequentially
increasing and decreasing the stimulus strength (the ‘‘up- and -
down’’ method), and the data were analyzed using the nonpara-
metric method of Dixon, as described by Chaplan et al [16].
Chronic constrictive injury (CCI) model
CCI model was performed following the method of Bennett and
Xie [17]. In brief, mice were anesthetized with sodium
pentobarbital (40-mg/kg, intraperitoneal injection). The left sciatic
nerve was exposed at mid-thigh level through a small incision and
a unilateral constriction injury just proximal to the trifurcation was
performed with three loose ligatures using a 5-0 silk thread (spaced
at a 1-mm interval). In sham-operated animals, the nerve was
exposed but not ligated. The incision was closed in layers, and the
wound was treated with antibiotics.
Sciatic nerve blockade model
According to the method reported by Leszczynska and Kau
[18], all mice were placed in the middle of a 20625-cm inverted
mesh and acclimatized to climb to the outside and over the edge of
the mesh, and mice could climb on mesh with all four limbs before
experiments. Mice were slightly restrained and drugs were injected
into the area of the popliteal fossa of the left hind limb using a 50-
ml Hamilton syringe with a 28-gauge needle. After injection, mice
were placed onto the mesh, and primary endpoint was the time to
loss of ability to hang on to the inverted mesh with the injected
hind limb, which was tested at 5, 10, 15, 20, 25 and 30 -min after
injection.
Immunohistochemistry
Mice were anesthetized with sodium pentobarbital (60-mg/kg,
intraperitoneal injection) and subjected to sternotomy followed
intracardial perfuse with 20-ml saline followed by 100-ml 4% ice-
cold paraformaldehyde in 0.1-mol/L phosphate buffer. The spinal
cord of L4–5 was removed, post-fixed in 4% paraformaldehyde for
3-h, and subsequently allowed to equilibrate in 30% sucrose in
phosphate buffer overnight at 4-uC. Thirty-mm transverse series
sections were cut on a cryostat and stored in phosphate buffer.
After washing in phosphate buffer saline, the tissue sections were
incubated in phosphate buffer saline containing 5% normal goat
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For the Fos protein assay, the sections were incubated in primary
polyclonal rabbit-anti-Fos antibody (1:1000) (Santa Cruz Biotech-
nology, Santa Cruz, CA) at 4-uC for 48-h. The sections were then
incubated in biotinylated goat anti-rabbit (1:200) at 37-uC for 1-h
and in avidin-biotin-peroxidase complex (1:100) (Vector Labs,
Burlingame, CA) at 37-uC for 2-h. Finally, the sections were
treated with 0.05% diaminobenzidine for 5–10-min. Sections were
rinsed in phosphate buffer saline to stop the reaction, mounted on
gelatin-coated slides, air-dried, dehydrated with 70%–100%
alcohol, cleared with xylene, and cover-slipped for microscopic
examination. To analyze the change of Fos protein expression, we
examined 5 L4–5 spinal cord sections per animal, selecting the
sections with the greatest number of positive neurons. For each
animal, we recorded the total number of positive neurons in the
bilateral spinal cord I,V lamina. All positive neurons were
counted without considering the intensity of the staining.
Western blot analysis
The spinal cords of the mice were quickly extracted and stored
in liquid nitrogen. Tissue samples were homogenized in lysis buffer
containing (in mM, pH 7.4): Tris 20.0, sucrose 250.0, Na3VO4
0.03, MgCl2 2.0, EDTA 2.0, EGTA 2.0, phenylmethylsulfonyl
fluoride 2.0, dithiothreitol 1.0, and protease inhibitor cocktail
0.02% (v/v). The homogenates were centrifuged at 5000-g for 30-
min at 4-uC. The supernatant was collected and protein
concentration was performed according to the Bradford (1976)
method using bovine serum albumin as a standard [19]. The
protein samples were stored at 280-uC.
Protein samples were dissolved in 4 6sample buffer (in mM,
pH 6.8): Tris-HCl 250.0, Sucrose 200.0, Dithiothreitol 300.0,
0.01% Coomassie brilliant blue-G, and 8% sodium dodecyl
sulfate, and denatured at 95-uC for 5-min. Then the equivalent
amounts of protein (80-mg) were separated using 10% sodium
dodecyl sulfate-polyacrylamide gel electrophoresis and transferred
onto nitrocellulose membrane. In addition, the gels stained with
Coomassie blue were used to confirm the equal amounts of protein
loaded on each lane. The membranes were incubated overnight at
4-uC with the primary polyclonal rabbit anti-p-ERK1/2 or anti-
ERK1/2 antibody (1:700, Bioword, St. Louis Park, MN). The
specificity for p-ERK antibodies was confirmed by loss of bands in
the absence of primary antibodies. The membranes were
extensively applied with Tris-Buffered Saline Tween-20 and
incubated for 2-h with the secondary antibody conjugated with
alkaline phosphatase (1:500, Santa Cruz, CA) at room tempera-
ture. The immune complexes were detected by using a nitro blue
tetrazolium/5-bromo-4-chloro-3-indolyl phosphate assay kit (Sig-
ma, St. Louis, MO). Western blot densitometry analysis of signal
intensity was performed using Adobe Photoshop software (Adobe,
San Jose, CA) and phosphorylation levels of ERK from
densitometry were normalized to total ERK. The blot density
from control groups was set as 100%.
Electrophysiological recordings
Electrophysiological recordings from DRG neurons were
performed with whole cell current- clamp recording methods
similar to previous studies [3]. Briefly, DRGs of 6-8-week-old
Sprague-Dawley rats were removed and placed in DMEM
containing 1% penicillin-streptomycin (Sigma, St. Louis, MO),
treated for 90-min with 5-mg/ml collagenase, 1-mg/ml Dispase II
(Roche), then with 0.25% trypsin for 7-min, followed by 2.5%
trypsin inhibitor. Cells were triturated in the presence of DNAase I
inhibitor (50-U), centrifuged through 15% BSA (Sigma, St. Louis,
MO), resuspended in 1-ml of Neurobasal medium (Sigma, St.
Louis, MO), 10-mm AraC, 50-ng/ml nerve growth factor and 2-
ng/ml glial cell line-derived neurotrophic factor and plated onto
35-mm tissue culture dishes (Becton Dickinson) coated with 500-
mg/ml polylysine and 5-mg/ml laminin, at 8,000–9,000 cells per
dish. Cultures were incubated at 37-uC under 5% CO2.
Recordings were made at room temperature within 48-h of
plating. The artificial cerebrospinal fluid used as bath solution was
composed of 128 NaCl, 3 KCl, 1.25 NaH2PO4, 10 D-glucose, 24
NaHCO3, 2 CaCl2, and 2 MgSO4, oxygenated with 95% O2 and
5% CO2 (in mM, pH 7.35, 295–300 -mOsm).
Whole cell patch-clamp recordings were made with an
Axoclamp 700B amplifier (Molecular Devices) from small DRG
neurons. Glass electrodes (4–6-MV) were fabricated with a
Flaming/Brown micropipette puller (P-97, Sutter instruments)
and were filled with an internal solution containing (in mM: 120
potassium gluconate, 20 KCl, 1 CaCl2, 2 MgCl2, 10 EGTA, 2
Mg-ATP, 0.5 Na2-GTP, and 10 HEPES (pH 7.2, 280–290 -
mOsm). Action potentials were evoked by 25-ms depolarizing
current pulses with 100-pA step amplitude in current patch clamp
mode, and total sodium current was recorded by applying a
depolarizing voltage pulse from the holding potential of 265 mV
to 25 mV in the presence of potassium and calcium channel
blockers in the voltage-clamp mode in DRG neurons. Data were
low-pass filtered at 2-kHz, digitized at a sampling rate of 10-kHz.
Drugs were applied through a solution perfusion system.
Statistical analysis
Data are expressed as mean 6 S.E.M. Statistical analysis of
more than two groups was performed using one-way analysis of
variance (ANOVA) followed by a Tukey’s post hoc test. The
significance of any differences in thermal latency threshold in the
behavior testing was assessed using two-way ANOVA. Time was
treated as a ‘within subjects’ factor and ‘treatment’ was treated as a
‘between subjects’ factor. The area under the pain threshold
change versus time curve was calculated by GraphPAD Prism5
(Graph Pad Software Inc., San Diego, CA) in some behavioral
testss. Statistical analyses of data were generated using GraphPAD
Prism5. All p values given are based on two-tailed tests. P,0.05
was considered as statistically significant.
Results
Acidic PBS induces TRPV1-mediated hyperalgesia and
spinal neuron sensitization
Previous studies have shown that H
+ (low pH) produced
hyperalgesia in animals and humans [8,12]. In agreement with
these reports, our results also show that intraplantar injection of
pH 5.0 PBS, but not pH 7.4 PBS, induced thermal and
mechanical hyperalgesia in mice which could last about 20-min
and return to baseline level at 30-min after intraplantar injection
of pH 5.0 PBS (Fig. 1A). Spinal neuronal sensitization was
involved in the development and maintenance of hyperalgesia. Fos
protein, the product of the c-fos immediate early gene, has been
used as a maker for neuronal activation in the central nervous
system [20,21]. There is a positive correlation between the
quantity of Fos protein expression and spinal neuronal activation
induced by nociceptive stimuli. Recent data suggested the expres-
sion of spinal p-ERK could act as a better marker for central
sensitization in pain studies [22]. To further clarify the algesic
effect of intraplantar injection of pH 5.0 PBS, we investigated the
change of spinal Fos protein at 2-h and p-ERK expression at 0–
30 min after intraplantar injection of pH 5.0 PBS. We found that
intraplantar injection of pH 5.0 PBS, and not pH 7.4 PBS,
induced a remarkable increase of spinal Fos protein and p-ERK
Acidic QX-314 and Selective Analgesia
PLoS ONE | www.plosone.org 3 December 2011 | Volume 6 | Issue 12 | e29395Figure 1. Intraplantar acid injection produced TRPV1-mediated time-dependent behavioral hyperalgesia and spinal neuron
sensitization. (A) Intraplantar injection of pH 5.0 PBS (10-ml), not pH 7.4 PBS (10-ml), produced thermal (top) and mechanical (bottom) hyperalgesia.
*P,0.05, from 5 to 25-min time point, pH 5.0 PBS group vs. pH 7.4 PBS group. Inset figures showed that the calculated area under curve (AUC)
(0,60-min) in paw-withdrawal latency (PWL) test was significantly decreased in pH 5.0 PBS group. **P,0.01 compared with pH 7.4 PBS group, n=8
mice in each group. (B) Representative immunohistochemical staining and quantitative data of Fos in the spinal cord of mice. Intraplantar injection of
pH 5.0 PBS (10-ml), but not pH 7.4 PBS (10-ml), increased spinal Fos protein expression. Quantitative data indicats the number of Fos positive neurons
in the spinal cord in each group. ***P,0.001 compared with pH 7.4 PBS group, n=6 mice in each group. Scale bar=100-mm. (C) The representative
bands (top) for the expression of p-ERK at different time points after injection of pH 5.0 PBS (10-ml) and the quantitative data (bottom) for the
expression of p-ERK. The fold change for the density of p-ERK is normalized to total-ERK for each sample. The fold change for the density of p-ERK
levels in the 0-time point group was set at 1 for quantification. Compared with 0 min time point, ***P,0.001 at 5 min, **P,0.01 at 10-min, *P,0.05
at 15-min, n=6 mice in each group. (D) Intraplantar injection of SB366791 (2.5-mg/10-ml) or amiloride (100-mg/10-ml), not DMSO (1%/10-ml), inhibited
acid-induced thermal and mechanical hyperalgesia. *P,0.05, from 5 to 25-min time point, SB366791+pH 5.0 PBS group vs. DMSO+pH 5.0 PBS group.
*P,0.05, from 15 to 25-min time point, amiloride+pH 5.0 PBS group vs. DMSO+pH 5.0 PBS group. Inset figures show that the calculated area under
curve (AUC) (0–60-min) in PWL and PWT tests were significantly increased in SB366791+pH 5.0 PBS group and amiloride (100-mg/10-ml)+pH 5.0 PBS
group. **P,0.01 compared with DMSO+pH 5.0 PBS group, n=8 mice in each group. (E) Representative immunohistochemical staining and
quantitative data of Fos in the spinal cord in mice. Intraplantar injection of SB366791 (2.5-mg/10-ml)+pH 5.0 PBS (10-ml), not amiloride(100-mg/10-
ml)+pH 5.0 PBS and DMSO (1%/10-ml)+pH 5.0 PBS (10-ml) group decreased spinal Fos protein expression. Quantitative data indicats the number of Fos
positive neurons in the spinal cord in each group. **P,0.01 compared with DMSO+pH 5.0 PBS group, n=6 mice in each group. (F) The representative
bands (top) for the expression of p-ERK after injection of SB366791 (2.5-mg/10-ml)+pH 5.0 PBS (10-ml), amiloride (100-mg/10-ml)+pH 5.0 PBS, or DMSO
(1%/10-ml)+pH 5.0 PBS (10-ml) group and the quantitative data (bottom) for the expression of p-ERK. The fold change for the density of p-ERK is
normalized to total-ERK for each sample. The fold change for the density of p-ERK levels in DMSO+pH 5.0 PBS group was set at 1 for quantifications.
Compared with DMSO+pH 5.0 PBS group, *P,0.05, n=6 mice in each group.
doi:10.1371/journal.pone.0029395.g001
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PLoS ONE | www.plosone.org 4 December 2011 | Volume 6 | Issue 12 | e29395Figure 2. Acidic QX-314 inhibited acid-induced behavioral hyperalgesia and spinal neuronal sensitization. (A) Time course of thermal
and mechanical hyperalgesia in control, pH 5.0 PBS+pH 5.0 PBS group, pH 5.0 QX-314+pH 5.0 PBS group, pH 7.4 PBS+pH 5.0 PBS group and pH 7.4
QX-314+pH 5.0 PBS group. The interval between the two injections was 15-min. **P,0.01 at 5-min and 10-min compared with control group,
###P,0.001,
##P,0.01,
#P,0.05 at 5-min to 25-min point,
$$P,0.01,
$P,0.05 at 15-min to 30-min compared with pH 5.0 PBS+pH 5.0 PBS group or
pH 7.4 PBS+pH 5.0 PBS, n=8 mice in each group. (B) Representative immunohistochemical staining and quantitative data of Fos in the spinal cord in
mice. Intraplantar pre-injection of pH 5.0 QX-314, but not pH 7.4 QX-314 attenuated the expression of spinal Fos protein induced by acid injection in
mice. ***P,0.001, pH 7.4 PBS+pH 7.4 PBS group vs. pH 5.0 PBS+pH 5.0 PBS group, pH 7.4 QX-314+pH 5.0 PBS group vs. pH 5.0 QX-314+pH 5.0 PBS
group, pH 5.0 QX-314+pH 5.0 PBS group vs. pH 5.0 PBS+pH 5.0 PBS group, n=6 mice in each group. Scale bar=100-mm. (C) The representative
western blot bands (top) and the quantitative data (bottom) for the expression of p-ERK in the mouse spinal cord. The fold change for the density of
p-ERK bands is calculated after normalization with t-ERK. p-ERK levels in pH 7.4 PBS+pH 7.4 PBS group were set at 1 for quantifications. **P,0.01,
pH 7.4 PBS+pH 7.4 PBS group vs. pH 5.0 PBS+pH 5.0 PBS group, pH 5.0 QX-314+pH 5.0 PBS group vs. pH 5.0 PBS+pH 5.0 PBS, *P,0.05, pH 7.4 QX-
314+pH 5.0 PBS group vs. pH 5.0 QX-314+pH 5.0 PBS group, n=6 mice in each group. (D) Application of pH 5.0 QX-314 (5 -mM), but not pH 7.4 QX-
314, blocked production of action potentials in primary DRG neurons. The first-forth and sixth panels: a depolarizing current step (100-pA, 25-ms)
applied to small DRG neurons evoked a nociceptor-like broad action potential when it was in the solutions of pH 7.4 ACSF, pH 7.4 ACSF+QX-314,
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lamina of the spinal cord (Fig. 1B). The increased expression of
spinal p-ERK lasted about 15-min and peaked at the 5-min time
point which was consistent with the pain behavior induced by
pH 5.0 PBS (Fig. 1C). Many studies have shown that TRPV1 and
ASIC participate in nociceptive information processing at the spinal
cord level. Therefore, we asked whether TRPV1 or ASIC were
involved in acid-induced hyperalgesia, the increased expression of
spinal Fos, and p-ERK. To address this question, SB366791 (2.5-
ug/10-ul),a TRPV1antagonist,oramiloride (100-ug/10-ul),a non-
selective ASIC antagonist, was injected 30-min before injection of
pH 5.0 PBS. The results show that SB366791 could completely
abolished pH 5.0 PBS-induced thermal and mechanical hyperal-
gesia and the increase of spinal Fos protein and p-ERK expression
(Fig. 1D, E, F). Injection of amiloride did not produce analgesic
effects at the 5-min and 10-min time points, however, analgesia
appeared 15-min after injection of pH 5.0 PBS. Injection of
amiloride did not inhibit the spinal Fos protein and p-ERK
expression (Fig. 1D, E, F). This result was in agreement with some
previous reports. Leffler et al reported that the main acid-sensor
unmyelinated nociceptorinmiceis TRPV1[23]. Amiloride was less
effective in reducing severe acidification (pH 5.0) -evoked pain [24].
These results further confirmed that acidic PBS induced TRPV1-
mediated hyperalgesia and spinal neuron sensitization.
Acidic QX-314 prevents acid-induced thermal
hyperalgesia, spinal neuron sensitization, and generation
of action potentials
QX-314 could be delivered into the nociceptors via the activated
TRPV1 channels by capcasin or chemical membrane permeation
enhancers in different models [3,4,5,6,8]. Now that acidic PBS
could activate the peripheral TRPV1 channels, acidic QX-314
should produce similar effects as capcasin. To test this speculation,
an acid-evoked pain model was induced by intraplantar injection of
pH 5.0PBS and pH 5.0 or pH 7.4 QX-314 (2%) 15-min before
administration of pH 5.0PBS. Present results indicated that
pretreatment with acidic QX-314 significantly inhibited acid-
induced thermal and mechanical hyperalgesia behavior. Further-
more, paw thermal latency in the pH 5.0QX-314 group washigher
than its baseline level. pH 7.4QX-314did not produce an analgesic
effectatthe 5-minand 10-mintimepoints.Itsanalgesiceffectshown
in the 15-min to 30-min time points should result from activating
TRPV1 channels by the subsequent injection of pH 5.0PBS
(Fig. 2A). The data from Fos and p-ERK expression further
confirmed the behavioral results. Pretreatment with pH 5.0, not
pH 7.4, QX-314 also significantly inhibited acid-induced increase
of spinal Fos and p-ERK expression (Fig. 2B,C).
Blockage of voltage-gated Na
+ channels could prevent the
generationandpropagation ofaction potentials. Next,weexamined
the effect of pH 5.0 and pH 7.4 QX-314 on action potentials
evoked by current injection in cultured dorsal root ganglia by
current patch clamp. After getting a small sized dorsal root ganglion
(DRG) cell in a voltage patch clamp, we switched the recording
mode form voltage patch clamp to current patch clamp and
recorded resting membrane potential. 100-pA current was injected
to produce action potentials in pH 7.4 ACSF. Then, pH 7.4 QX-
314 was washed in for 10-min. 100-pA current injection could still
induce action potentials. Next, we washed out pH 7.4 QX-314 for
20-min and washed in pH 5.0 ACSF for 10-min. The number of
action potentials was less, but it could be evoked when the cells were
bathed in pH 5.0 ACSF. Finally, we washed in pH 5.0 QX-314 for
10-min and found that current injection, even 6 times more, could
not evoke the generation of action potentials. The effect of pH 5.0
QX-314 could be washed out (Fig. 2D). Finally, to investigate the
effect of pH 5.0 QX-314 on sodium current, total sodium current
was recorded in the voltage-clamp mode in DRG neurons by
applying a depolarizing voltage pulse from the holding potential of
265 mV to 25 mV in the presence of potassium and calcium
channel blockers. After recording a sodium current in pH 7.4 PBS,
pH 7.4 QX-314 was washed in for 5-min; sodium current was
elicited bythisdepolarizing voltagepulsealthough itsamplitudewas
reduced slightly. However, sodium current was almost completely
blocked by the following pH 5.0 QX-314 wash. This effect could be
washed out by pH 7.4 PBS (Fig. 2E). These results were in
accordance with behavioraland immunohistochemical findings and
demonstrated that QX-314 could enter into cells and block sodium
channels by delivery in an acidic solution.
TRPV1, not ASIC, mediates the analgesic effects of acidic
QX-314
Both TRPV1 and ASIC are expressed in peripheral nociceptors
and their cellular bodies DRG and could be activated by acid
solution. Therefore, we want to know which one or if both channels
were involved in the analgesic effect of acidic QX-314. To answer
this question, SB366791 (2.5-ug/10-ul) or the ASIC antagonist
amiloride (100-mg/10-ul) was injected at 25-min or 10-min before
injection of pH 5.0 QX-314. We found that pretreatment with
SB366791 completely prevented the analgesic effect of acidic QX-
314 (Fig. 3A). However, pretreatment with amiloride could enhance
the analgesic effect of acidic QX-314 (Fig. 3A). Furthermore,
pretreatment with SB366791, not amiloride, could also prevent the
inhibition of acid-induced Fos and p-ERK expression by acidic
QX-314 (Fig. 3B,C). Next, we performed electrophysiological
recordings to further confirm the above results. 100-pA current was
injected to produce action potentials in cells treated with pH 5.0
DMSO. Then, pH 5.0 SB366791 was washed in for 10-min. 100-
pA current injection still could induce action potentials. Next, we
washed in pH 5.0 SB366791 QX-314 for 20-min and saw that
action potentials still could be evoked. Finally, we washed out
pH 5.0 SB366791 QX-314 for 30-min and washed in pH 5.0
amiloride QX-314 for 10-min and found that current injection,
even 6 times more, could not evoke the generation of action
potentials, suggesting TRPV1, not ASIC, channels mediated the
analgesic effect of acidic QX-314 (Fig. 3D).
Acidic QX-314 produces analgesic effect in a
noradrenaline-induced pain model
Previous studies have shown that injection of noradrenaline (NE)
can cause pain in human and animals [25,26]. In the present
experiment, we used this pain model to further confirm the
analgesic effect of acidic QX-314. In agreement with previous
reports, intraplantar injection of NE (0.5%, 10-ml) produced a
significant thermal and mechanical hyperalgesic behavior in mice
which could last at least 60-min (Fig. 4A). This injection also
increased spinal Fos and p-ERK expression (Fig. 4C, D).
Pretreatment with pH 5.0, but not pH 7.4, QX-314 at 15-min
washout, pH 5.0 ACSF and washout. The fifth panel: pH 5.0 ACSF+QX-314 applied together completely abolished action potential generation even
with a larger current injection (600-pA). (E) pH 5.0 QX-314 (5-mM), but not pH 7.4 QX-314, blocked total sodium current in DRG neurons. Total sodium
current was recorded in DRG neurons by applying a depolarization voltage pulse from the holding potential of 265 mV to 25 mV in the voltage-
clamp mode.
doi:10.1371/journal.pone.0029395.g002
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PLoS ONE | www.plosone.org 6 December 2011 | Volume 6 | Issue 12 | e29395Figure 3. TRPV1 channels, but not ASIC, inhibited the analgesic property of acidic QX-314. (A) Time course of thermal and mechanical
hyperalgesia in SB+pH 5.0 QX-314+pH 5.0 PBS group, DMSO+pH 5.0 QX-314+pH 5.0 PBS group and amiloride+pH 5.0 QX-314+pH 5.0 group.
SB366791 (2.5-mg/10-ml) or amiloride (100-mg/10-ml) was given at 25-min before pH 5.0 QX-314 injection and at 40-min before pH 5.0 PBS injection,
***P,0.001, **P,0.01, *P,0.05 at 5-min to 25-min time point, and
#P,0.05 at 10-min to 20-min time point compared with DMSO+pH 5.0 QX-
314+pH 5.0 PBS group, n=8 mice in each group. (B) Representative immunohistochemical staining of Fos in the spinal cord of mice in the
DMSO+pH 5.0 QX-314+pH 5.0 PBS group, SB366791+pH 5.0 QX-314+pH 5.0 PBS group and amiloride+pH 5.0 QX-314+pH 5.0 PBS group.
Quantitative data indicates the number of Fos positive neurons in the spinal cord in each group. ***P,0.001, DMSO+pH 5.0 QX-314+pH 5.0 PBS
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PLoS ONE | www.plosone.org 7 December 2011 | Volume 6 | Issue 12 | e29395beforeinjectionofNEpreventedNE-inducedpainbehaviorandthe
increaseofspinalFosandp-ERKexpression.Aboveeffectscouldbe
abolished by pre-injection of TRPV1 inhibitor SB366791 (Fig. 4B,
C, D). These results further demonstrated that acidic QX-314 could
produce the analgesic effect mediated by TRPV1 channels.
Sciatic nerve blockage with acidic QX-314 produces
sensory-specific analgesic effects in naı ¨ve and chronic
neuropathic pain in mice
TRPV1 channels are not expressed in neurons of motor nerves.
Therefore, QX-314 entry into cells mediated by capsaicin-
activated TRPV1 channels only blocks sensory nerves and does
not affect motor nerve function. Knowing that the analgesic effect
of acidic QX-314 is mediated by TRPV1 channels, we predict that
it should only block sensory nerves and have no effect on motor
nerves. In the present study, we found that injection of acidic QX-
314 (2%, 20-ml) into the popliteal space produced a significant
sensory blockade without any impairment on movement. Howev-
er, mice given a lidocaine injection experienced a 15–25-min
paralysis. Both of the agents induced a similar sensory blockage for
about 30-min and returned to the baseline level at 40-min after
injection (Fig. 5A,B,E). Next, we wanted to know whether
injection of acidic QX-314 also produced analgesic effect in
chronic pain status. To address this question, a neuropathic pain
model induced by chronic constrictive injury (CCI) was performed
and 2% acidic QX-314 was injected into the popliteal space at 5
days after CCI, and then thermal hyperalgesia and mechanical
allodynia were measured at different time points after injection of
acidic QX-314. We found that acidic QX-314 produced a
significant analgesic effect without any impairment of motor nerve
function (Fig. 5C,D). In some clinical cases, LA needs to be
employed repeatedly. To test whether the repeated injection of
acidic QX-314 could produce a similar effect for each time, we
intraplantarly injected pH 5.0 QX-314 three times at intervals of
60-min. The present results showed each injection had a similar
time-course and intensity of sensory blockage (Fig. 5E).
Discussion
The present study showed the following findings (1) acidic QX-
314 prevented acid or NE-induced thermal and mechanical
hyperalgesia and the increase of spinal Fos and p-ERK expression,
which could be abolished by TRPV1 antagonist SB366791 and
not by the ASIC antagonist amiloride. (2) pH 5.0, not pH 7.4,
QX-314 blocked sodium currents and abolished the current
injection-evoked generation of action potentials in DRG neurons;
the latter could be prevented by SB366791 and not by amiloride.
(3) acidic QX-314 produced the analgesic effect without
impairment of motor functions in mouse sciatic nerve blockage
model in naı ¨ve and CCI mice. These findings indicated that acidic
QX-314 selectively blocks sensory nerves mediated by a TRPV1-
dependent mechanism.
LA have covered a long history since cocaine was first employed
in clinics in the late 19
th Century, and increasingly more LA have
appeared since then [27]. Almost of all LA produced analgesic
effects by interrupting neuron excitation and conduction via
blockage of voltage-gated sodium channels. Therefore, it was
unavoidable to impair movement as well as block pain sensation.
Recently, Woolf and colleagues reported that co-administration of
capsaicin and QX-314 produces a long-lasting sensory-specific
blockade [3]. Accumulated evidence has built the theory that QX-
314 enters into the nociceptors via activated-TRPV1 channels or
surfactants-induced penetration of the cell membrane and blocks
the Na
+ channels from the intracellular side [3,4,5,6,7]. What we
know is that QX-314 acts as a local anesthetic only when it is
delivered into the nociceptors. However, these methods of drug
combination would induce some side effects and also were
inconvenient to use. In the present study, we found that acidic
QX-314 can produce selective analgesia similar to those
combinations. The pH value of clinically-used LA such as
lidocaine and bupivacaine is pH 3-5.5 in hydrochlorate or
carbonate form. So, the pH value of the solution used in this
study is acceptable within those limits.
There was a viewpoint that low pH solution injected into
peripheral tissue was buffered quickly and was unsuitable as a
medium for introducing QX-314 intracellularly [4]. In this study,
we found that injection of pH 5.0 PBS resulted in marked
thermal hyperalgesia (lasting for 15–20-min) and sensitization of
spinal neurons manifesting as activation of spinal p-ERK and c-
Fos, which could be prevented by pretreatment with a TRPV1
antagonist, indicating injection of acidic solution peripherally
could activate TRPV1 channels. Based on the results of our
behavioral test, spinal p-ERK, and Fos expression, we thought
that intraplantar injection of 10-ml acidic solution had enough
time to activate TRPV1 channels or other channels like ASIC
before it was buffered, which usually is an immediate process, and
TRPV1-mediated downstream activation (for example, ERK
signaling pathway) would keep the TRPV1 channels open at later
time points to save enough time for QX-314 entering intra-
cellularly. Furthermore, we found that acidic QX-314 and not
neutral pH QX-314 alleviated acid- and NE-induced thermal
hyperalgesia, inhibited spinal p-ERK and Fos expression, and
abolished production of action potentials. Next, we injected
acidic QX-314 into the popliteal space and found that this
injection induced a significant sensory blockage without any
impairment of movement. These results provide strong evidence
that acidic solution can be used as medium for introducing QX-
314 into cells, which could produce a selective analgesic effect in
vivo. The duration of analgesic effect of acidic QX-314 was
shorter than what was induced by capsaicin-activated TRPV1
channels or by chemical membrane permeation enhancers
[3,28,29]. However, the similar time-course and intensity of
blockade produced by repeated injection could make up for the
short-acting deficiency of QX-314. Actually, short-acting LA are
group vs. SB366791+pH 5.0 QX-314+pH 5.0 PBS group, SB366791+pH 5.0 QX-314+pH 5.0 PBS group vs. amiloride+pH 5.0 QX-314+pH 5.0 PBS group,
n=6 in each group. Scale bar=100-mm. (C) p-ERK was examined at 10-min after pH 5.0 PBS injection, and the representative western blot bands (top)
and the quantitative data (bottom) for the expression of p-ERK in the spinal cord of mice is shown. The fold change for the density of p-ERK bands is
calculated after normalization with the DMSO+pH 5.0 QX-314+pH 5.0 PBS group. p-ERK levels in the DMSO+pH 5.0 QX-314+pH 5.0 PBS group was
set at 1 for quantifications. **P,0. 01, DMSO+pH 5.0 QX-314+pH 5.0 PBS group vs. SB366791+pH 5.0 QX-314+pH 5.0 PBS group; *P,0. 05,
SB366791+pH 5.0 QX-314+pH 5.0 PBS group vs. amiloride+pH 5.0 QX-314+pH 5.0 PBS, n=6 mice in each group. (D) Application of SB366791 (10-
mM), but not amiloride (100-mM), prevented the blockage effect of pH 5.0 QX-314 on production of action potentials in primary DRG neurons. The
first-forth and sixth panels: a depolarizing current step (100-pA, 25-ms) applied to small DRG neurons evoked a nociceptor-like broad action potential
when it was in the solutions of pH 5.0 ACSF+DMSO, pH 5.0 ACSF+SB366791, pH 5.0 ACSF+SB366791-QX-314, washout and pH 5.0 ACSF+amiloride.
The sixth panel: pH 5.0 ACSF+amiloride-QX-314 applied together completely abolished action potential generation even with larger current
injections (600-pA).
doi:10.1371/journal.pone.0029395.g003
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PLoS ONE | www.plosone.org 8 December 2011 | Volume 6 | Issue 12 | e29395Figure 4. Acidic QX-314 inhibited NE-induced behavioral hyperalgesia and spinal neuronal sensitization. (A) Pre-treatment with pH 5.0
QX-314 (2.5-mg/10-ml) inhibited thermal and mechanical hyperalgesia induced by intraplantar injection of NE (0.5%, 10-ml). **P,0.01 or *P,0.05 at 5-
min to 40-min time point compared with NE or pH 7.4 QX-314+NE group, n=8 mice in each group. (B) Pre-injection of SB366791 prevented the
analgesic effect of pH 5.0 QX-314 in NE-induced thermal hyperalgesia in mice. ***P,0.001, **P,0.01 or *P,0.05 at 5-min to 55-min time point
compared with SB366791+pH 5.0 QX-314+NE, n=8 mice in each group. (C) Intraplantar injection of pH 5.0 QX-314, but not pH 7.4 QX-314,
attenuated the expression of spinal Fos protein induced by NE in mice, which could be abolished by pre-injection of SB366791. Representative
immunohistochemical staining of Fos in the spinal cord of mice in the control group, DMSO group, NE group, pH 7.4 QX-314+NE group, pH 5.0 QX-
314+NE group and SB366791+pH 5.0 QX-314+NE group. Quantitative data indicates the number of Fos positive neurons in the spinal cords of mice in
each group. ***P,0.001, NE group vs. control group or DMSO group; pH 7.4 QX-314+NE group vs. pH 5.0 QX-314+NE group, pH 5.0 QX-314+NE
group vs. SB366791+pH 5.0 QX-314+NE group, n=6 mice in each group. Scale bar=100-mm. (D) p-ERK was examined at 10-min after pH 5.0 PBS
injection. The representative western blot bands (top) and the quantitative data (bottom) for the expression of p-ERK in the spinal cord of mice are
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PLoS ONE | www.plosone.org 9 December 2011 | Volume 6 | Issue 12 | e29395also useful in some clinical cases. We also intrathecally injected
acidic QX-314 and found that some of the mice that received this
injection died after an immediate irritation (data not shown),
which is consistent with a recent study reported by Schwarz et al
[30]. We will investigate the reason and mechanisms of this
phenomenon in following experiments.
shown. The fold change for the density of p-ERK bands is calculated after normalization with control. p-ERK levels in control group were set at 1 for
quantifications. **P,0.01, NE group vs. control group or DMSO group, pH 5.0 QX-314+NE group vs. SB366791+pH 5.0 QX-314+NE group;
***P,0.001, pH 7.4 QX-314+NE group vs. pH 5.0 QX-314+NE group, n=6 in each group.
doi:10.1371/journal.pone.0029395.g004
Figure 5. Sciatic nerve blockage with acidic QX-314 produced sensory-specific analgesic effect in naı ¨ve and chronic neuropathic
pain mice. (A) Time course of thermal and mechanical hyperalgesia after injection of lidocaine (2%, 20 -ml) and pH 5.0 QX-314 (2%, 20 -ml) in the sciatic
nerve blockage model in naı ¨ve mice. ***P,0.001, **P,0.01, *P,0.05 or ##P,0.01, #P,0.05 at 10-min to 40-min time point compared with control
group, n=8 mice in each group. (B) Time course of thermal and mechanical hyperalgesia after injection of pH 5.0 QX-314 (2%, 20-ml) in the sciatic nerve
blockage model in CCI mice. ***P,0.001, **P,0.01, *P,0.05 in the 10-min to 60-min time point compared with CCI group, n=8 mice in each group. (C)
Injectionof lidocaine, but not pH 5.0 QX-314into the sciatic nerve produced motor blockage. Theoffset time was defined as the time point at which the
mouse regained its ability to use the treated hind limb to hang on to the inverted mesh. Mice were tested 10-min after injection until recovery. Survival
fractions were calculated using the product limit (Kaplan-Meier) method. (D) Time course of thermal hyperalgesia after repeated injection of pH 5.0 QX-
314, ***P,0.001, **P,0.01, *P,0.05 at the 20-min to 170-min time point compared with control group. n=6 mice in each group.
doi:10.1371/journal.pone.0029395.g005
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PLoS ONE | www.plosone.org 10 December 2011 | Volume 6 | Issue 12 | e29395The present study found that acidic QX-314 prevents acid- and
NE-induced thermal and mechanical hyperalgesia, spinal neuron
sensitization and production of action potentials, which could be
prevented by SB366791, a TRPV1 antagonist, but not by
amiloride, an antagonist of ASIC. Both TRPV1 and ASIC
channels were activated by acid injection and involved in pain
behavior. We didn’t investigate which channel prominently
contributed to the acid-induced pain. However, TRPV1 channels,
not ASIC, mediated the analgesic property of acidic QX-314.
In conclusion, we have demonstrated that administration of
acidic QX-314 can provide a sensory-selective nerve blockage in
different models. These findings have important implications for
exploring QX-314 as a novel LA and suggest that acidic QX-314
solution may have potential for clinical use.
Acknowledgments
We thank Dr. Cooper DC and Davalyn Powell from University of
Colorado for English editing.
Author Contributions
Conceived and designed the experiments: JLC LCZ YPW YMZ.
Performed the experiments: HL HXZ HYH XFL JQW CGW. Analyzed
the data: HL HXZ. Wrote the paper: JLC HL HXZ.
References
1. Strichartz G (1976) Molecular mechanisms of nerve block by local anesthetics.
Anesthesiology 45: 421–441.
2. Butterworth JF, 4th, Strichartz GR (1990) Molecular mechanisms of local
anesthesia: a review. Anesthesiology 72: 711–734.
3. Binshtok AM, Bean BP, Woolf CJ (2007) Inhibition of nociceptors by TRPV1-
mediated entry of impermeant sodium channel blockers. Nature 449: 607–610.
4. Ries CR, Pillai R, Chung CC, Wang JT, MacLeod BA, et al. (2009) QX-314
produces long-lasting local anesthesia modulated by transient receptor potential
vanilloid receptors in mice. Anesthesiology 111: 122–126.
5. Gerner P, Binshtok AM, Wang CF, Hevelone ND, Bean BP, et al. (2008)
Capsaicin combined with local anesthetics preferentially prolongs sensory/
nociceptive block in rat sciatic nerve. Anesthesiology 109: 872–878.
6. Kim HY, Kim K, Li HY, Chung G, Park CK, et al. (2010) Selectively targeting
pain in the trigeminal system. Pain 150: 29–40.
7. Sagie I, Kohane DS (2010) Prolonged sensory-selective nerve blockade. PNAS
107: 3740–3745.
8. Jones NG, Slater R, Cadiou H, McNaughton P, McMahon SB (2004) Acid-
Induced Pain and Its Modulation in Humans. J Neurosci 24: 10974–10979.
9. Davies JW, Hainsworth AH, Guerin CJ, Lambert DG (2010) Pharmacology of
capsaicin-, anandamide-, and N-arachidonoyl-dopamine-evoked cell death in a
homogeneous transient receptor potential vanilloid subtype 1 receptor
population. Br J Anaesth 104: 596–602.
10. Kissin I (2008) Vanilloid-induced conduction analgesia: selective, dose-
dependent, long-lasting, with a low level of potential neurotoxicity. Anesth
Analg 107: 271–281.
11. Jhaveri MD, Elmes SJ, Kendall DA, Chapman V (2005) Inhibition of peripheral
vanilloid TRPV1 receptors reduces noxious heat-evoked responses of dorsal
horn neurouns in naive, carrageenan-inflamed and neuropathic rats.
Eur J Neurosci 22: 361–370.
12. Drizin I, Gomtsyan A, Bayburt EK, Schmidt RG, Zheng GZ, et al. (2006)
Strcture-activity studies of a novel series of 5,6-fused heteroaromatic ureas as
TRPV1 antagonists. Bioorg Med Chem 14: 4740–4749.
13. Levine JD, Aleddandri-Haber N (2007) TRP channels: Targets for the relief of
pain. Biochimica et Biophysica Acta 1772: 989–1003.
14. Caterina MJ, Schaumacher MA, Tominaga M, Rosen TA, Levine JD, et al.
(1997) The capsaicin receptor: a heat-activated ion channel in the pain pathway.
Nature 389: 816–824.
15. Hargreaves K, Dubner R, Brown F, Flores C, Joris J (1988) A new and sensitive
method for measuring thermal nociception in cutaneous hyperalgesia. Pain 32:
77–88.
16. Chaplan SR, Bach FW, Pogrel JW, Chung JM, Yaksh TJ (1994) Quantitative
assessment of tactile allodynia in the rat paw. J Neurosci Methods 53: 55–63.
17. Bennett GJ, Xie YK (1988) A peripheral mononeuropathy in rat that produces
disorders of pain sensation like those seen in man. Pain 33: 87–107.
18. Leszczynska K, Kau ST (1992) A sciatic nerve blockade method to differentiate
drug-induced local anesthesia from neuromuscular blockade in mice.
J Pharmacol Toxicol Methods 27: 85–93.
19. Bradford MM (1976) A rapid and sensitive method for the quantitation of
microgram quantities of protein utilizing the principle of protein–dye binding.
Anal Biochem 72: 248–254.
20. Coggeshall RE (2005) Fos, nociception and the dorsal horn. Prog Neurobiol 77:
299–352.
21. Munglani R, Fleming BG, Hunt SP (1996) Remembrance of times past: the
significance of c–fos in pain. Br J Anaesth 76: 1–4.
22. Gao YJ, Ji RR (2009) c-Fos and pERK, which is a better marker for neuronal
activation and central sensitization after noxious stimulation and tissue injury?
Open Pain J 2: 11–17.
23. Leffler A, Mo ¨nter B, Koltzenburg M (2006) The role of the capsaicin receptor
TRPV1 and acid-sensing ion channels (ASICS) in proton sensitivity of
subpopulations of primary nociceptive neurons in rats and mice. Neuroscience
139: 699–709.
24. Ugawa S, Ueda T, Ishida Y, Nishigaki M, Shibata Y, et al. (2002) Amiloride-
blockable acid-sensing ion channels are leading acid sensors expressed in human
nociceptors. J Clin Invest 110: 1185–1190.
25. Fuchs PN, Meyer RA, Raja SN (2001) Heat, but not mechanical hyperalgesia,
following adrenergic injections in normal human skin. Pain 90: 15–23.
26. Banik RK, Sato J, Yajima H, Mizumura K (2001) Differences between the Lewis
and Sprague-Dawley rats in chronic inflammation induced norepinephrine
sensitivity of cutaneous C-fiber nociceptors. Neurosci Lett 299: 21–24.
27. Pilcher JE (1886) II. Cocaine as an Anaesthetic; Its Status at the Close of the
First Year of its Use. Ann Surg 3: 51–66.
28. Binshtok AM, Gerner P, Oh SB, Puopolo M, Suzuki S, et al. (2009)
Coapplication of lidocaine and the permanently charged sodium channel
blocker QX-314 produces a long-lasting nociceptive blockade in rodents.
Anesthesiology 111: 127–137.
29. Lim TK, MacLeod BA, Ries CR, Schwarz SK (2007) The quaternary lidocaine
derivative, QX-314, produces long-lasting local anesthesia in animal models in
vivo. Anesthesiology 107: 305–311.
30. Schwarz SK, Cheung HM, Ries CR, Lee SM, Wang JT, et al. (2010) Lumbar
intrathecal administration of the quaternary lidocaine derivative, QX-314,
produces irritation and death in mice. Anesthesiology 113: 438–444.
Acidic QX-314 and Selective Analgesia
PLoS ONE | www.plosone.org 11 December 2011 | Volume 6 | Issue 12 | e29395